Rocio Salas-Whalen is a board-certified endocrinologist at New York Endocrinology in New York, New York
Trimi's program is positioned as a cash-pay option
However, the evidence is preliminary so far, with a small pilot study finding that liraglutide reduced the number of monthly headache days
Cagrilintide monotherapy weight loss In the phase 2 trial over 26 weeks, cagrilintide weight loss ranged from 6.0% to 10.8% of body weight depending on dose
Prescribing Semaglutide Patient Assessment: Factors such as medical history, current medications, comorbidities, and lifestyle should be considered to determine the appropriateness of semaglutide for a particular individual
Semaglutide matches GLP-1 (glucagon-like peptide-1), a unique hormone in the body that is responsible for controlling appetite